Clinical trial
Effect of IVIg on Pregnancy Rate of Patient With Recurrent Implantation Failure With Immunological Causes
NCT03174964 is registered in ClinicalTrials.gov with Tabriz University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of IVIg on Pregnancy Rate of Patient With Recurrent Implantation Failure With Immunological Causes
- Lead sponsor
- Tabriz University of Medical Sciences
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 20, 2016
- Completion date
- September 20, 2017
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent implantation failure